Filing excerpt
Net cash used in investing activities was $620.6 million for the twenty-six weeks ended August 2, 2026, primarily consisting of... $85.6 million for capital expenditures related to expanding operations at our fulfillment centers, veterinary clinics, and future pharmacy facility capabilities.